Immunohistochemical distinction between mesothelial and adenocarcinoma cells in serous effusions: A combination panel-based approach with a brief review of the literature

Indian Journal of Pathology and Microbiology

Volumn 52, Issue 2, 2009, Pages 175-181

  Murugan, Paari ^a,b   Siddaraju, Neelaiah ^a   Habeebullah, Syed ^a   Basu, Debdatta ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^b NONE   (India)

Author keywords

Adenocarcinoma; Immunohistochemistry; Reactive mesothelial cells; Serous effusions

Indexed keywords

CALRETININ; CARCINOEMBRYONIC ANTIGEN; DESMIN; EPITHELIAL MEMBRANE ANTIGEN; TUMOR MARKER; UVOMORULIN; VIMENTIN;

ADENOCARCINOMA; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DIAGNOSTIC ACCURACY; EFFUSION; FISHER EXACT TEST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MESOTHELIUM CELL; PREDICTION AND FORECASTING; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SEROSA;

ADENOCARCINOMA; BIOLOGICAL MARKERS; CADHERINS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CARCINOEMBRYONIC ANTIGEN; CYTOLOGICAL TECHNIQUES; DESMIN; FEMALE; HUMANS; MUCIN-1; PERICARDIAL EFFUSION; PLEURAL EFFUSION; SENSITIVITY AND SPECIFICITY; VIMENTIN;

EID: 63449124467     PISSN: 03774929     EISSN: None     Source Type: Journal    
DOI: 10.4103/0377-4929.48910     Document Type: Article

References (23)

1. To A, Coleman DV, Dearnaley DP, Ormerod MG, Steele K, Neville AM. Use of antisera to epithelial membrane antigen for the cytodiagnosis of malignancy in serous effusions. J Clin Pathol 1981;34:1326-32.
2. Singh HK, Silverman JF, Berns L, Haddad MG, Park HK. Significance of epithelial membrane antigen in the work-up of problematic serous effusions. Diagn Cytopathol 1995;13:3-7.
3. Davidson B. Ovarian carcinoma and serous effusions: Changing views regarding tumor progression and review of current literature. Anal Cell Pathol 2001;23:107-28.
4. nd ed. Philadelphia: WB Saunders Co;1997. p. 551-621.
5. DeMay R. Fluids. In: DeMay R, editor. The art and science of cytopathology. Chicago: American Society of Clinical Pathologists;1996. p. 257-325.
6. Pereira TC, Saad RS, Liu Y, Silverman JF. The diagnosis of malignancy in effusion cytology: A pattern recognition approach. Adv Anat Pathol 2006;13:174-84.
7. Saleh H, Bober P, Tabaczka P. Value of Ki67 immunostain in identification of malignancy in serous effusions. Diagn Cytopathol 1999;20:24-8.
8. Leiman G. The cytopathology of serous effusions: The cavalry has arrived-with reinforcements. Curr Diagn Pathol 2001;7:123-30.
9. Bedrossian CW. Special stains, the old and the new: The impact of immunocytochemistry in effusion cytology. Diagn Cytopathol 1998;18:141-9.
10. Lee JS, Nam JH, Lee MC, Park CS, Juhng SW. Immunohistochemical panel for distinguishing between carcinoma and reactive mesothelial cells in serous effusions. Acta Cytol 1996;40:631-6.
11. Jensen ML, Johansen P. Immunocytochemical staining of smears and corresponding cell blocks from serous effusions: A follow-up and comparative investigation. Diagn Cytopathol 1996;15:33-6.
12. Delahaye M, van der Ham F, van der Kwast TH. Complementary value of five carcinoma markers for the diagnosis of malignant mesothelioma, adenocarcinoma metastasis, and reactive mesothelium in serous effusions. Diagn Cytopathol 1997;17:115-20.
13. Schofield K, D'Aquila T, Rimm DL. E-cadherin expression is a sensitive and specific method for detection of carcinoma cells in fluid specimens. Diagn Cytopathol 2000;22:263-7.
14. Simsir A, Fetsch P, Mehta D, Zakowski M, Abati A. E-cadherin, N-cadherin, and calretinin in pleural effusions: The good, the bad, the worthless. Diagn Cytopathol 1999:20:125-30.
15. Motherby H, Nadjari B, Friegel P, Kohaus J, Ramp U, Böcking A. Diagnostic accuracy of effusion cytology. Diagn Cytopathol 1999;20:350-7.
16. Davidson B, Risberg B, Kristensen G, Kvalheim G, Emilsen E, Bjåmer A, et al. Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies: Evaluation of five epithelial markers. Virchows Arch 1999;435:43-9.
17. Chhieng DC, Yee H, Cangiarella JF, Symmans WF, Cohen JM. Use of E-cadherin and CD44 aids in the differentiation between reactive mesothelial cells and carcinoma cells in pelvic washings. Cancer 2000;90:299-306.
18. Gupta RK, Kenwright DN, Fauck R, Lallu S, Naran S. The usefulness of a panel of immunostains in the diagnosis and differentiation of metastatic maqlignancies in pericardial effusions. Cytopathology 2000;11:312-21.
19. Ko EC, Jhala NC, Shultz JJ, Chhieng DC. Use of a Panel of Markers in the Differential Diagnosis of Adenocarcinoma and Reactive Mesothelial Cells in Fluid Cytology. Am J Clin Pathol 2001;116:709-15.
20. Lozano MD, Panizo A, Toledo GR, Sola JJ, Pardo-Mindán J. Immunocytochemistry in the differential diagnosis of serous effusions: A comparative evaluation of eight monoclonal antibodies in papanicolaou stained smears. Cancer 2001;93:68 -72.
21. Politi E, Kandaraki C, Apostolopoulou C, Kyritsi T, Koutselini H. Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids. Diagn Cytopathol 2005;32:151-5.
22. Malle D, Valeri RM, Photiou C, Kaplanis K, Andreadis C, Tsavdaridis D, et al. Significance of Immunocytochemical expression of E-cadherin, N-Cadherin and CD 44 in serous effusions using liquid-based cytology. Acta Cytol 2005;49:11-6.
23. Ueda J, Iwata T, Ono M, Takahashi M. Comparison of three cytologic preparation methods and immunocytochemistries to distinguish adenocarcinoma cells from reactive mesothelial cells in serous effusion. Diagn Cytopathol 2006;34:6-10.